headbg headbg
 
Home

About Us

Database

Links

News

Contact
 | 
 

EUROCARE-5

  1. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE‑5 study
    Magdalena B.L.; Silvia R.; Michalina K.; Annemie H.; Augius D.; Roberta De A.; Adam M.; Miguel R.B.; Vesna Z.; Pamela M.; EUROCARE5 Working Group.
    Archives of Gynecology and and Obstetrics 2019. Document
  1. Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study
    Stiller C.A.; Botta L.; Brewster D.H.; Ho V.K.Y.; Frezza A.M.; Whelan J.; Casali P.G.; Trama A.; Gatta G.; EUROCARE-5 Working Group.
    Cancer Epidemiolgy 2018,56:146-153. Document
  1. A population-based comparison of European and North American sinonasal cancer survival
    Unsal A.A.; Kiliç S.; Dubal P.M.; Baredes S.; Eloy J.A.; EUROCARE-5 Working Group.
    Auris nasus larynx 2018,45:815-824. Document
  1. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis
    Minicozzi P.; Walsh P.M.; Sánchez M.J.; Trama A.; Innos K.; Marcos-Gragera R.; Dimitrova N.; Botta L.; Johannesen T.B.; Rossi S.; Sant M.; The EUROCARE-5 Working Group.
    European Journal of Cancer 2018,5:127-137. Document
  1. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
    Minicozzi P.; Innos K.; Sánchez M.J.; Trama A.; Walsh P.M.; Marcos-Gragera R.; Dimitrova N.; Botta L.; Visser O.; Rossi S.; Tavilla A.; Sant M.; The EUROCARE-5 Working Group.
    European Journal of Cancer 2017,84:335-353. Document
  1. Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5
    Dal Maso L.; Tavilla A.; Pacini F.; Serraino D.; van Dijk BAC.; Chirlaque Lopez M.D.; Capocaccia R.; Mallone S.; De Angelis R.; The EUROCARE-5 Working Group.; et al.
    European Journal of Cancer 2017,77:140-152. Document
  1. Geographical variability in survival of European children with
    central nervous system tumours
    Gatta G.; Peris-Bonet R.; Visser O.; Stiller C.; Marcos-Gragera R.; Sánchez M.-J.;
    Lacour B.; Kaatsch P.; Berrino F.; Rutkowsky S.; Botta L.;
    and the EUROCARE-5 Working Group.
    European Journal of Cancer 2017,82:137-148. Document
  1. Trends in net survival from 15 cancers in six European Latin countries:
    the SUDCAN population-based study material
    Crocetti E.; Bossard N.; Uhry Z.; Roche L.; Rossi S.; Capocaccia R.; Faivre J.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s3-s8. Document
  1. New insights into survival trend analyses in cancer population-based studies: the SUDCAN methodology
    Uhry Z.; Bossard N.; Remontet L.; Iwaz J.; Roche L.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s9-s15. Document
  1. Trends in net survival from head and neck cancer in sixEuropean Latin countries: results from the SUDCAN population-based study
    Guizard A.; Uhry Z.; De Raucourt D.; Mazzoleni G.; Sánchez M.J.; Ligier K.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s16-s23. Document
  1. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study
    Launoy G.; Bossard N.; Castro C.; Manfredi S.; the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s24-s31. Document
  1. Trends in net survival from stomach cancer in six European Latin countries:
    results from the SUDCAN population-based study
    Glória L.; Bossard N.; Bouvier A.M.; Mayer-da-Silva A.; Faivre J.; Miranda A.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s32-s39. Document
  1. Trends in net survival from colon cancer in six European Latin countries:
    results from the SUDCAN population-based study
    Faivre J.; Bossard N.; Jooste V.; the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s40-s47. Document
  1. Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study
    Lepage C.; Bossard N.; Dejardin O.; Carmona-Garcia M.C.; Manfredi S.; Faivre J.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s48-s55. Document
  1. Trends in net survival from liver cancer in six European Latin countries:
    results from the SUDCAN population-based study
    Ferretti S.; Bossard N.; Binder-Fouchard F.; Faivre J.; Bordoni A.; Biavati P.;
    Frassoldati A.; the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s56-s62. Document
  1. Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based study
    Bouvier A.M.; Bossard N.;Colonna M.; Velasco A.G.; Carulla M.; Manfredi S.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s63-s69. Document
  1. Trends in net survival lung cancer in six European Latin countries:
    results from the SUDCAN population-based study
    Bordoni A.; Uhry Z.;Antunes L.; the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s70-s76. Document
  1. Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study
    Galceran J.; Uhry Z.;Marcos-Gragera R.; Borràs J.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s77-s84. Document
  1. Trends in net survival from breast cancer in six European Latin countries: results from the SUDCAN population-based study
    Crocetti E.; Roche L.;Buzzoni C.; Di Costanzo F.; Molinié F.; Caldarella A.;
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s85-s91. Document
  1. Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study
    Haelens A.; Roche L.;Bastos J.; Woronoff A. S.; Zorzi M.; Francart J.; the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s92-s99. Document
  1. Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study
    Antunes L.; Roche L.; Bento M. J.; the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s100-s106. Document
  1. Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study
    Chirlaque M. D.; Uhry Z.; Salmerón D.; Sánchez-Zapata M. I.; Zannoni G. F.; Navarro C.; 
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s107-s113. Document
  1. Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study
    Grosclaude P.; Roche L.; Fuentes-Raspall R.; Larrañaga N.; 
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s114-s120. Document
  1. Trends in net survival from kidney cancer in six European Latin countries: results from the SUDCAN population-based study
    Mangone L.; Bossard N.; Marcos-Gragera R.; Pezzarossi A.; Roncaglia F.; Rossi P.G.; 
    the GRELL EUROCARE-5 Working Group.
    European Journal of Cancer Prevention 2017,26:s121-s127. Document
  1. Changes in dynamics of excess mortality rates and net survival after diagnosis
    of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)
    Mounier M.; Bossard N.; Remontet L.; Belot A.; Minicozzi P.; De Angelis R.; Capocaccia R.; Iwaz J.; Monnereau A.; Troussard X.; Sant M.; Maynadié M.; Giorgi R.;
    for the EUROCARE-5 Working Group CENSUR Working Survival Group.
    The Lancet Haematology 2015,11:e481-e491. Document
  1. Survival variations by country and age for lymphoid and myeloid malignancies
    in Europe 2000–2007: Results of EUROCARE-5 population-based study
    De Angelis R.; Minicozzi P.; Sant M.; Dal Maso L.; H. Brewster D.; Osca-Gelis G.; Visser O.; Maynadié M.; Marcos-Gragera R.; Troussard X.; Agius D.; Roazzi P.; Meneghini E.; Monnereau A.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2254-2268. Document
  1. Survival patterns in lung and pleural cancer in Europe 1999–2007:
    Results from the EUROCARE-5 study
    Francisci S.; Minicozzi P.; Pierannunzio D.; Ardanaz E.; Eberle A.; K. Grimsrud T.; Knijn A.; Pastorino U.; Salmerón D.; Trama A.; Sant M.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2242-2253. Document
  1. Survival of adults with primary malignant brain tumours in Europe;
    Results of the EUROCARE-5 study
    Visser O.; Ardanaz E.; Botta L.; Sant M.; Tavilla A.; Minicozzi P.;
    the EUROCARE-5 Working Group.
    the European Journal of Cancer 2015,51:2231-2241. Document
  1. Urinary tract cancer survival in Europe 1999–2007: Results of the
    population-based study EUROCARE-5
    Marcos-Gragera R.; Mallone S.; A. Kiemeney L.; Vilardell L.; Malats N.; Allory Y.; Sant M.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2217-2230. Document
  1. Survival of male genital cancers (prostate, testis and penis) in
    Europe 1999–2007: Results from the EUROCARE-5 study
    Trama A.; Foschi R.; Larrañaga N.; Sant M.; Fuentes-Raspall R.; Serraino D.; Tavilla A.;
    Van Eycken L.; Nicolai N.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2206-2216. Document
  1. Survival of women with cancers of breast and genital organs in Europe
    1999–2007: Results of the EUROCARE-5 study
    Sant M.; Chirlaque Lopez M.D.; Agresti R.; Sánchez Pérez M.J.; Holleczek B.; Bielska-Lasota M.; Dimitrova N.; Innos K.; Katalinic A.; Langseth H.; Larrañaga N.; Rossi S.; Siesling S.;
    Minicozzi P.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2191-2205. Document
  1. Survival of patients with skin melanoma in Europe increases further:
    Results of the EUROCARE-5 study
    Crocetti E.; Mallone S.; Robsahm T.E.; Gavin A.; Agius D.; Ardanaz E.; Chirlaque Lopez M.D.; Innos K.; Minicozzi M.; Borgognoni L.; Pierannunzio D.; Eisemann N.;
    the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2179-2190. Document
  1. Survival in patients with primary liver cancer, gallbladder and extrahepatic
    biliary tract cancer and pancreatic cancer in Europe 1999–2007:
    Results of EUROCARE-5
    Lepage C.; Capocaccia R.; Hackl M.; Lemmens V.; Molina E.; Pierannunzio D.; Sant M.; Trama A.; Faivre J.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2169-2178. Document
  1. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study
    Holleczek B.; Rossi S.; Agius D.; Innos K.; Minicozzi P; Francisci S.; Hackl M.; Eisemann N.; Brenner H.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2158-2168. Document
  1. Survival for oesophageal, stomach and small intestine cancers in Europe
    1999–2007: Results from EUROCARE-5
    Anderson L.A.; Tavilla A.; Brenner H.; Luttmann S.; Navarro C.; Gavin A.T.; Holleczek B.; Johnston B.T.; Cook M.B.; Bannon F.; Sant M.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2144-2157. Document
  1. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
    Gatta G.; Botta L.; Sánchez M.J.; Anderson L.A.; Pierannunzio D.; Licitra L.;
    the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2130-2143. Document
  1. Age and case mix-standardised survival for all cancer patients in Europe
    1999–2007: Results of EUROCARE-5, a population-based study
    Baili P.; Di Salvo F.; Marcos-Gragera R.; Siesling S.; Mallone S.; Santaquilani M.; Micheli A.; Lillini R.; Francisci S.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2120-2129. Document
  1. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods
    Rossi S.; Baili P.; Capocaccia R.; Caldora M.; Carrani E.; Minicozzi P.; Pierannunzio D.; Santaquilani M.; Trama A.; Allemani A.; Belot A.; Buzzoni C.; Lorez M.; De Angelis R.; the EUROCARE-5 Working Group.
    European Journal of Cancer 2015,51:2104-2119. Document
  1. Survival for haematological malignancies in Europe between 1997 and 2008
    by region and age: results of EUROCARE-5, a population-based study
    Sant M.; Minicozzi P.; Maunier M.; Anderson L.A.; Brenner H.; Holleczek B.;
    Marcos-Gragera R.; Maynadié M.; Monnereau A.; Osca-Gelis G.; Visser O.;
    De Angelis R.; the EUROCARE-5 Working Group.
    Lancet Oncology 2014,15:931-942. Document
  1. Cancer survival in Europe 1999-2007 by country and age: results
    of EUROCARE-5-a population-based study
    De Angelis R.; Sant M.; Coleman M.P.; Francisci S.; Baili P.; Pierannunzio D.; Trama A.; Visser O.; Brenner H.; Ardanaz E.; the EUROCARE-5 Working Group.;  et al.
    Lancet Oncology 2014,15:23-34. Document      Paper
  1. Childhood cancer survival in Europe 1999-2007: results
    of EUROCARE-5-a population-based study
    Gatta G.; Botta L.; Rossi S.; Aareleid T.; Bielska-Lasota M.; Clavel J.; Dimitrova N.; Jakab Z.; Kaatsch P.; Lacour B.; Mallone S.; the EUROCARE Working Group.;  et al.
    Lancet Oncology 2014,15:35:47. Document      Paper

EUROCARE-4

  1. Survival and cure trends for European children, adolescents and youn adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002
    Gatta G.; Rossi S.; Foschi R.; Trama A.; Marcos-Gragera R.; Pastore G.; Peris-Bonet R.; Stiller C.; Capocaccia R.; the EUROCARE Working Group.
    Haematologica 2013,98:744-752. Document
  1. Variation in cancer survival and patterns of care across Europe: roles of wealth and health-care organizzation
    Gatta G.; Trama A.; Capocaccia R.
    National Cancer Institute Monograph 2013,46:79-87. Document
  1. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease
    Minicozzi P.; Berrino F.; Sebastiani F.; Falcini F.; Vattiato R.; Ciccoloni F.; et al. 
    European Journal of Cancer 2013,49:3881-3888. Document
  1. Relative and disease-free survival for breast cancer in relation to subtype:
    a population-based study
    Minicozzi P.; Bella F.; Toss A.; Giacomin A.; Fusco M.; Zarcone M.; Tumino R.; et al. 
    Journal Cancer Research Clinical Oncology 2013,139:1569-1577. Document
  1. Impact of diabetes on overall and cancer-specific mortality in
    colorectal cancer patients
    Bella F.; Minicozzi P.; Giacomin A.; Crocetti E.; Federico M.; Ponz de Leon M.; Tumino R.; Mangone L.; Giuliani O.; Budroni M.; Sant M.
    Journal Cancer Research Clinical Oncology 2013,139:1303-1310. Document
  1. Patterns of adjuvant chemotherapy for stage II and III colon cancer
    in France and Italy
    Bouvier A.M.; Minicozzi P.; Grosclaude P.; Bouvier V.; Faivre J.; Sant M.
    Journal Cancer Research Clinical Oncology 2013,139:1303-1310. Document
  1. Key factors influencing lung cancer survival in northern Italy
    Mangone L.; Minicozzi P.; Vicentini M.; Giacomin A.; Caldarella A.; Cirilli C.; Falcini F.;
    Giorgi Rossi P.; Sant M.
    Cancer Epidemiology 2013,37:226-232. Document
  1. Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study
    Minicozzi P.; Kaleci S.; Maffei S.; Allemani C.; Giacomin A.; Caldarella A.; Iachetta F.;
    Fusco M.; Tumino R. et al.
    European Journal of Public Health 2013. Document
  1. Predictions of survival up to 10 years diagnosis for European women with breast cancer in 2000-2002
    Allemani C.; Minicozzi P.; Berrino F.; Bastiaannet E.; Gavin A.; Galceran J.; Ameijide A.; Siesling S.; Mangone L. et al.
    International Journal Cancer 2013,132:2404-2412. Document
  1. Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study
    Maynadié M.; De Angelis R.; Marcos-Gragera R.; Visser O.; Allemani C.; Tereanu C.; Capocaccia R.; Giacomin A.; et al.
    Haematologica 2013,98:230-238. Document
  1. Cancer prevalence estimates in Europe at the beginning of 2000
    Gatta G.; Mallone S.; van der Zwan J.M..; Trama A.; Siesling S.; Capocaccia R.;
    EUROCARE Working Group.
    Annals of Oncology 2013,24:1660-1666. Document
  1. Oesophageal cancer survival in Europe: A EUROCARE-4 study
    Gavin A.T.; Francisci S.; Foschi R.; Donnelly D.W.; Lemmens V.; Brenner H.;
    Anderson L.A.; the EUROCARE-4 Working Group
    Cancer Epidemiology 2012,36:505-512. Document
  1. Regional inequalities in cancer care persist in Italy and can influence survival
    Sant M.; Minicozzi P.; Allemani C.; Cirilli C.; Federico M.; Capocaccia R.; Budroni M.;
    Candela P.; Crocetti E.; et al.
    Cancer Epidemiology 2012,36:541-547. Document
  1. Looking at differences in stage and treatment of colorectal cancers across Italy: a EUROCARE-5 high resolution study
    Minicozzi P.; Caldarella A.; Giacomin A.; Ponz de Leon M.; Cesaraccio R.; Falcini M.; Fusco M.; Iachetta F.; Pellegri C.; Tumino R.; Capocaccia R.; Sant M.
    Tumori 2012,98:671-677. Document
  1. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study
    Brenner H.; Bouvier A.M.; Foschi R.; Hackl M.; Larsen I.K.; Lemmens V.; Mangone L.; Francisci S.; EUROCARE Working Group.
    International Journal of Cancer 2012,131:1649-1658. Document
  1. Survival for Ovarian Cancer in Europe: The across-country variation
    did not shrink in the past decade
    Oberaigner W.; Minicozzi P.; Bielska-Lasota M.; Allemani C.; De Angelis R.; Mangone L.;
    Sant M.; the EUROCARE Working Group.
    Acta Oncologica 2012,51:441-453. Document
  1. Survival of European patients with central nervous system tumors
    Sant M.; Minicozzi P.; Lagorio S.; Borge Johannesen T.; Marcos-Gragera R.; Francisci S.;
    the EUROCARE Working Group.
    International Journal of Cancer 2012,131:173-185. Document
  1. Differences in stage and treatment of breast cancer across Italy point to inequalities in access to and availability of proper care
    Minicozzi P.; Cirilli C.; Federico M.; Capocaccia R.; Budroni M.; Candela P.; Falcini F.;
    Fusco M.; Giacomin A.; La Rosa F.; Traina A.; Tumino R.; Sant M.
    Tumori 2012,98:204-209. Document
  1. Survival of European patients diagnosed with lymphoid neoplasms in
    2000-2002: results of the HAEMACARE project
    Marcos-Gragera R.; Allemani C.; Tereanu C.; De Angelis R.; Capocaccia R.; Maynadie M.; Luminari S.; et al.
    Haematologica 2011,96:720-728. Document
  1. Do pre-diagnostic drinking habits influence breast cancer survival?
    Allemani C.; Berrino F.; Krogh V.; Sieri S.; Pupa S.M.; Tagliabue E.; Tagliabue G.; Sant M.
    Tumori 2011,97:142-148. Document
  1. Progress in colorectal cancer survival in Europe from the late 1980s to the
    21st century: the Eurocare study
    Brenner H.; Bouvier A. M.; Foschi R.; Hackl M.; Larsen I.K.; Lemmens V.; Mangone L.;
    Francisci S.; the EUROCARE Working Group.
    International Journal of Cancer 2011. Document
  1. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999:
    a population-based study
    Zigon G.; Berrino F.; Gatta G.; Sanchez M.J.; van Dijk B.; Van Eycken E.; Francisci S.;
    the EUROCARE Working Group.
    Annalsof Oncology 2011,22:165-174. Document
  1. Population-based incidence of childhood leukaemias and lymphomas
    in Spain (1993-2002)
    Marcos-Gragera R.; Cervantes-Amat M.; Vicente M.L.; de Sanjose S.; Guallar E.;
    Godoy C.; Calvo C.; Giraldo O.; Sant M.; et al.
    European Journal of Cancer Prevention 2010,19:247-255. Document
  1. Manual for coding and reporting haematological malignancies.
    Sant M.; Karjalainen-Lindsberg M.L.; Maynadie M.; Raphael M.; Ferretti S.;
    Giacomin A.; Tereanu C.; et al.
    Tumori 2010,96:1-32. Document
  1. Incidence of hematologic malignancies in Europe by morphologic subtype:
    results of HAEMACARE project
    Sant M.; Allemani C.; Tereanu C.; De Angelis R.; Capocaccia R.; Visser O.;
    Marcos-Gragera R.; Simonetti A.; the HAEMACARE Working Group; et al.
    Blood 2010,116:3724-34. Document
  1. What reasons lie behind long-term survival differences for gastric
    cancer within Europe?
    Bouvier A.M.; Sant M.; Verdecchia A.; Forman D.; Damhuis R.;
    Coebergh J.W.; Crocetti E.; et al.
    European Journal of Cancer 2010,46:1086-1092. Document
  1. Operative mortality after gastric cancer resection and long-term survival differences across Europe
    Lepage C.; Sant M.; Verdecchia A.; Forman D.; Esteve J.; Faivre J.;
    and the EUROCARE Working Group.
    British Journal of Surgery 2010,97:235-239. Document
  1. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: A EUROCARE High Resolution Study
    Gatta G.; Zigon G.; AAreleid T.; Ardanaz E.; Bielska-Lasota M.; Galceran J.; Gozdz S.; Hakulinen T.; et al.
    Acta Oncologica 2010,49:776-783. Document
  1. Survival from salivary glands adenoid cystic carcinoma in European populations
    Ciccolallo L.; Licitra L.; Cantù G.; Gatta G.; the EUROCARE Working Group.
    Oral Oncology 2009,45:669-674. Document
  1. Prostate cancer treatment in Europe at the end of 1990s
    Gatta G.; Zigon G.; Buemi A.; Coebergh J.W.; Contiero P.; Denis L.; et al.
    Acta Oncologica 2009,48:867-873. Document
  1. Comparative cancer survival information in Europe
    Berrino F.; Verdecchia A.; Lutz J.M.; Lombardo C.; Micheli A.; Capocaccia R.;
    the EUROCARE Working Group.
    European Journal of Cancer 2009,45:901-908. Document
  1. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis
    De Angelis R.; Francisci S.; Baili P.; Marchesi F.; Roazzi P.; Belot A.;
    the EUROCARE Working Group.; et al.
    European Journal of Cancer 2009,45:909-930. Document
  1. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999.
    Results and commentary
    Sant M.; Allemani C.; Santaquilani M.; Knijn A.; Marchesi F.; Capocaccia R.; 
    the EUROCARE Working Group.
    European Journal of Cancer 2009,45:931-991. Document
  1. Survival of European children and young adults with cancer
    diagnosed 1995-2002
    Gatta G.; Zigon G.; Capocaccia R.; Coebergh J.W.; Desandes E.; Kaatsch P.; 
    Pastore G.; Peris-Bonet R.; Stiller C.A.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:992-1005. Document
  1. The cancer survival gap between elderly and middle-aged patients
    in Europe is widening
    Quaglia A.; Tavilla A.; Shack L.; Brenner H.; Janssen-Heijnen M.; Allemani C.; 
    Colonna M.; Grande E.; Grosclaude P.; Vercelli M.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1006-1016. Document
  1. The advantage of women in cancer survival: An analysis of EUROCARE-4 data
    Micheli A.; Ciampichini R.; Oberaigner W.; Ciccolallo L.; de Vries E.; Izarzugaza I.; 
    Zambon P.; Gatta G.; De Angelis R.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1017-1027. Document
  1. Long-term survival expectations of cancer patients in Europe in 2000-2002
    Brenner H.; Francisci S.; De Angelis R.; Marcos-Gragera R.; Verdecchia A.; 
    Gatta G.; Sant M.; the EUROCARE Working Group.; et al.
    European Journal of Cancer 2009,45:1028-1041. Document
  1. Survival trends in European cancer patients diagnosed from 1988 to 1999
    Verdecchia A.; Guzzinati S.; Francisci S.; De Angelis R.; Bray F.; Allemani C.; 
    Tavilla A.; Santaquilani M.; Sant M.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1042-1066. Document
  1. The cure of cancer: A European perspective
    Francisci S.; Capocaccia R.; Grande E.; Santaquilani M.; Simonetti A.; Allemani C.; 
    Gatta G.; Sant M.; Zigon G.; Bray F.; Janssen-Heijnen M.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1067-1079. Document
  1. Multiple tumours in survival estimates
    Rosso S.; De Angelis R.; Ciccolallo L.; Carrani E.; Soerjomataram I.; Grande E.; Zigon G.;
    Brenner H.;  the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1080-1094. Document
  1. Survival in patients with uveal melanoma in Europe
    Virgili G.; Gatta G.; Ciccolallo L.; Capocaccia R.; Biggeri A.; Crocetti E.; Lutz J.M.; Paci E.; the EUROCARE Working Group.
    Archives of Ophtalmology 2008,126:1413-1418. Document
  1. Human papillomavirus in HNSCC: a European epidemiologic perspective
    Licitra L.; Zigon G.; Gatta G.; Sanchez M.J.; Berrino F.; the EUROCARE Working Group.
    Hematology Oncology Clinics of North America 2008,22:1143-1153. Document
  1. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
    Verdecchia A.; Francisci S.; Brenner H.; Gatta G.; Micheli A.; Mangone L.; et al.
    Lancet Oncology 2007,8:784-796. Document
  1. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
    Berrino F.; De Angelis R.; Sant M.; Rosso S.; Lasota M.B.; Coebergh J.W.; et al.
    Lancet Oncology 2007,8:773-783. Document

 (top...)

EUROCARE-3

  1. Variation in 'standard care' for breast cancer across Europe:
    a EUROCARE-3 high resolution study
    Allemani C.; Storm H.; Voogd A.C.; Holli K.; Izarzugaza I.; Torrella-Ramos A.; et al.
    European Journal of Cancer 2010,46:1528-1536. Document
  1. European disparities in malignant digestive endocrine tumours survival
    Lepage C.; Ciccolallo L.; De Angelis R.; Bouvier A.M.; Faivre J.; Gatta G.; and the EUROCARE Working Group.
    International Journal of Cancer 2010,126:2928-2934. Document
  1. Survival for ethmoid sinus adenocarcinoma in European populations
    Gatta G.; Bimbi G.; Ciccolallo L.; Zigon G.; Cantu' G.; the EUROCARE Working Group.
    Acta Oncologica 2009,48:992-998. Document
  1. Survival from salivary glands adenoid cystic carcinoma in European populations
    Ciccolallo L.; Licitra L.; Cantu' G.; Gatta G.; the EUROCARE Working Group.
    Oral Oncology 2009,45:669-674. Document
  1. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States
    Sant. M.; Allemani C.; De Angelis R.; Carbone A.; De Sanjosè S.; Gianni A.M.; Giraldo P.; Marchesi F.; Marcos-Gragera R.; Martos-jimenez C.; Maynadié M.; Raphael M.; Berrino F.;
    EUROCARE-3 Working Group.
    European Journal of Cancer 2008, 44:579-587. Document
  1. Incidence of Uveal Melanoma in Europe
    Virgili G.; Gatta G.; Ciccolallo L.; Capocaccia R.; Buggeri A.; et al.
    Ophthalmology 2007,114:2309-2315. Document
  1. Hepatocellular carcinoma: trends of incidence and survival in Europe and United States at the end of the 20th century
    Capocaccia R.; Sant M.; Berrino F.; Simonetti A.; Santi V.; Trevisani F.; et al.
    American Journal of Gastroenterology 2007,102:1661-1670. Document
  1. Trends in cervical cancer survival in Europe, 1983-1994:
    A population-based study
    Lasota M.B.; Inghelmann R.; Van de Poll-Franse L.; Capocaccia R.;
    the EUROCARE Working Group.
    Gynecologic Oncology 2007,105:609-619. Document
  1. A wide difference in cancer survival between middle aged
    and elderly patients in Europe
    Quaglia A.; Capocaccia R.; Micheli A.; Carrani E.; Vercelli M.;
    and the EUROCARE-3 Working Group.
    International Journal of Cancer 2007,120:2196-2201. Document
  1. Hodgkin disease survival in Europe and the U.S.
    Allemani C.; Sant M.; De Angelis R.; Gragera R.M.; Coebergh J.W.;
    and the Eurocare Working Group.
    Cancer 2006,107:352-360. Document
  1. Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over the period 1983-1994(EUROCARE-3 study)
    Colonna M.; Grande E.; Jonasson J.G.; EUROCARE Working Group.
    European Journal of Cancer 2006,42:2598-2608. Document
  1. Incidence of and survival from Wilms' tumour in adults in Europe: Data from the EUROCARE study
    Emmanuel M.; Ciccolallo L.; Coleman M.P.; Gatta G.; Pritchard-Jones K.; EUROCARE Working Group.
    European Journal of Cancer 2006,42:2363-2368. Document
  1. Survival from rare cancer in adults: a population-based study
    Gatta G.; Ciccolallo L.; Kunkler I.; Capocaccia R.; Berrino F.; Coleman M.P.; et al.
    Lancet Oncology 2006,7:132-140. Document
  1. Seasonal variation in the occurrence of cutaneous melanoma in Europe:
    influence of latitude. An analisis using the EUROCARE group of registries
    Boniol M.; De Vries E.; Coebergh J.W.; Dore, J.F.; EUROCARE Working Group.
    European Journal of Cancer 2005,41:126-132. Document
  1. Childhood cancer survival trends in Europe: A EUROCARE Working Group Study
    Gatta G.; Capocaccia R.; Stiller C.; Kaatsh P.; Berrino F.; Terenziani M.; et al.
    Journal of Clinical Oncology 2005,23:3742-3751. Document
  1. Explaining gastric cancer survival differences among european countries
    Verdecchia A.; Corazziari I.; Gatta G.; Lisi D.; Faivre J.; Forman D.; et al.
    International Journal of Cancer 2004,109:737-741. Document
  1. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe
    De Vries E.; Boniol M.; Dore, J.F.; Coebergh J.W.; EUROCARE Working Group.
    European Journal of Cancer 2004,40:1045-1052. Document
  1. Breast carcinoma survival in Europe and the United States – A population-based study
    Sant M.; Allemani C.; Berrino F.; Coleman M.P.; Aareleid T.; et al.
    Cancer 2004,100:715-722. Document
  1. Cancer survival in European adolescents and young adults
    Gatta G.; Capocaccia R.; De Angelis R.; Stiller C.; Coebergh J.W.
    European Journal of Cancer 2003,39:2600-2610. Document
  1. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology
    Gatta G.; Ciccolallo L.; Capocaccia R.; Coleman M.P.; Hakulinen T.; Møller H.; Berrino F.
    European Journal of Cancer 2003,39:2214-2222. Document
  1. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
    Sant M.; Allemani C.; Capocaccia R.; Hakulinen T.; Aareleid T.; Coebergh J.W.;
    Coleman M.P.; Grosclaude P.; Martinez C.; Bell J.; Youngson J.; Berrino F.
    International Journal of Cancer 2003,106:416-422. Document
  1. Electronic availability of EUROCARE-3 data: a tool for further analysis
    Roazzi P.; Capocaccia R.; Santaquilani M.; Carrani E.
    Annals of Oncology 2003,14:v150-v155. Document
  1. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
    Coleman M. P.; Gatta G.; Verdecchia A.; Estève J.; Sant M.; Storm H.; Allemani C.; Ciccolallo L.; Santaquilani M.; Berrino F.
    Annals of Oncology 2003,14:v128-v149. Document
  1. Childhood cancer survival in Europe
    Gatta G.; Corazziari I.; Magnani C.; Peris-Bonet R.; Roazzi P.; Stiller C.
    Annals of Oncology 2003,14:v119-v127. Document
  1. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
    Sant M.; Aareleid T.; Berrino F.; Lasota M.B.; Carli P.M.; Faivre J.; Grosclaude P.;
    Hédelin G.; Matsuda T.; Møller H.; Möller T.; Verdecchia A.; Capocaccia R.; et al.
    Annals of Oncology 2003,14:v61-v118. Document
  1. European health systems and cancer care
    Micheli A.; Coebergh J. W.; Mugno E.; Massimiliani E.; Sant M.; Oberaigner W.; Holub J.; Storm H. H.; Forman D.; Quinn M.; Aareleid T.; Sankila R.; Hakulinen T.; et al.
    Annals of Oncology 2003,14:v41-v60. Document
  1. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas
    Micheli A.; Baili P.; Quinn M.; Mugno E.; Capocaccia R.; Grosclaude P.
    Annals of Oncology 2003,14:v28-v40. Document
  1. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis
    Capocaccia R.; Gatta G.; Roazzi P.; Carrani E.; Santaquilani M.; De Angelis R.; Tavilla A.
    Annals of Oncology 2003,14:v14-v27. Document
  1. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies
    Berrino F.
    Annals of Oncology 2003,14:v9-v13. Document

 (top...)

EUROPREVAL

  1. Cancer prevalence in Northern Europe: the EUROPREVAL study
    Möller T.; Anderson H.; Aareleid T.; Hakulinen T.; Storm H.; Tryggvadottir L.; Corazziari I.; Mugno E.
    Annals of Oncology 2003,14:946-957. Document
  1. Cancer prevalence in the UK: results from the EUROPREVAL study
    Forman D.; Stockton D.; Møller H.; Quinn M.; Babb P.; De Angelis R.; Micheli A.
    Annals of Oncology 2003,14:648-654. Document
  1. Cancer prevalence in central Europe :the EUROPREVAL study
    Lutz J.M.; Francisci S.; Mugno E.; Usel M.; Pompe-Kirn V.; Coebergh J.W.;
    Bieslka-Lasota M.; On behalf of the EUROPREVAL Working Group.
    Annals of Oncology 2003,14:313-322. Document
  1. A comparative analysis of cancer prevalence in cancer registry areas of France,
    Italy and Spain
    Verdecchia A.; Micheli A.; Colonna M.; Moreno V.; Izarzugaza M.I.; Paci E.
    Annals of Oncology 2002,13:1128-1139. Document
  1. Cancer Prevalence in European Registry Areas
    Micheli A.; Mugno E.; Krogh V.; Quinn M.J.; Coleman M.; Hakulinen T.; Gatta G.;
    Berrino F.; Capocaccia R.
    Annals of Oncology 2002,13:840-865. Document
  1. Measuring cancer prevalence in Europe: the EUROPREVAL Project
    Capocaccia R.; Colonna M.; Corazzieri I.; De Angelis R.; Francisci S.; Micheli A.; Mugno E.
    Annals of Oncology 2002,13:831-839. Document

 (top...)

EUROCARE-2

  1. Cancer Survival Differences Between European Populations: the UK Uneasiness
    Gatta G.; Capocaccia R.; and Berrino F.
    British Journal of Cancer 2001,85:785-786. Document
  1. Cancer Survival
    Forman D.; Gatta G.; Capocaccia R.; Janssen-Heijnen M.L.G.; and Coebergh J.W.W.
    Lancet 2001,357:555. Document
  1. Cancer survival increases in Europe, but international differences remain wide
    Sant M.; Capocaccia R.; Coleman M.P.; Berrino F.; Gatta G.; Micheli A.;
    Verdecchia A.; et. al.
    European Journal of Cancer 2001,37:1659-1667. Document
  1. Childhood cancer survival in Europe and the United States
    Gatta G.; Capocaccia R.; Coleman M.P.; Gloeckler Ries L.A.; Berrino F.
    Cancer 2002,95:1767-1772. Document
  1. Differences in stage and therapy for breast cancer across Europe
    Sant M.; EUROCARE Working Group.;
    International Journal of Cancer 2001,93:894-901. Document
  1. Childhood cancer survival in Europe: an overview
    Terracini B.; Coebergh J.-W.; Gatta G.; Magnani C.; Stiller C.; Verdecchia A.; Zappone A.
    European Journal of Cancer 2001,37:810-816. Document
  1. Childhood cancer mortality in Europe, 1955–1995
    Levi F.; La Vecchia C.; Negri E.; Lucchini F.
    European Journal of Cancer 2001,37:785-809. Document
  1. Childhood melanoma in Europe since 1978: a population-based survival study
    Conti E.M.S.; Cercato M.C.; Gatta G.; Ramazzotti V.; Roscioni S.
    European Journal of Cancer 2001,37:780-784. Document
  1. Survival of children with thyroid cancer in Europe 1978–1989
    Storm H.H.; Plesko I.
    European Journal of Cancer 2001,37:775-779. Document
  1. Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study
    Stiller C.A.; Stevens M.C.G.; Magnani C.; Corazziari I.
    European Journal of Cancer 2001,37:767-774. Document
  1. Survival of children with bone sarcoma in Europe since 1978: results from
    the EUROCARE study
    Stiller C.A.; Craft A.W.; Corazziari I.
    European Journal of Cancer 2001,37:760-766. Document
  1. Survival of children with malignant germ cell, trophoblastic and other gonadal tumours in Europe
    Kramárová E.; Mann J.R.; Magnani C.; Corraziari I.; Berrino F.
    European Journal of Cancer 2001,37:750-759. Document
  1. Survival of children with liver tumours in Europe 1978–1989
    Möller T.R.; Garwicz S.; Corazziari I.; Magnani C.
    European Journal of Cancer 2001,37:744-749. Document
  1. Survival of children with Wilms' tumour in Europe
    Pleško I.; Kramárová E.; Stiller C.A.; Coebergh J.-W.; Santaquilani M.
    European Journal of Cancer 2001,37:736-743. Document
  1. Survival for retinoblastoma in Europe
    Sant M.; Capocaccia R.; Badioni V.
    European Journal of Cancer 2001,37:730-735. Document
  1. Survival of children with neuroblastoma: time trends and regional differences in Europe, 1978–1992
    Spix C.; Aareleid T.; Stiller C.; Magnani C.; Kaatsch P.; Michaelis J.
    European Journal of Cancer 2001,37:722-729. Document
  1. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study
    Magnani C.; Aareleid T.; Viscomi S.; Pastore G.; Berrino F.
    European Journal of Cancer 2001,37:711-721. Document
  1. Survival of childhood lymphomas in Europe, 1978–1992: a report from
    the EUROCARE study
    Pastore G.; Magnani C.; Verdecchia A.; Pession A.; Viscomi S.; Coebergh J.W.W.
    European Journal of Cancer 2001,37:703-710. Document
  1. Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study
    Gatta G.; Luksch R.; Coleman M.P.; Corazziari I.
    European Journal of Cancer 2001,37:695-702. Document
  1. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978–1992: the EUROCARE study
    Coebergh J.W.; Pastore G.; Gatta G.; Corazziari I.; Kamps W.
    European Journal of Cancer 2001,37:687-694. Document
  1. Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis
    Magnani C.; Gatta G.; Corazziari I.; Kramarova E.; Pastore G.; Viscomi S.; Stiller C.
    European Journal of Cancer 2001,37:678-686. Document
  1. The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses
    Berrino F.; Gatta G.; Sant M.; Capocaccia R.
    European Journal of Cancer 2001,37:673-677. Document
  1. Childhood cancer survival in Europe, 1978–1992: The EUROCARE Study
    Coebergh J.W.W.; Capocaccia R.; Gatta G.; Magnani C.; Stiller C.A.
    European Journal of Cancer 2001,37:671-672. Document
  1. Toward a Comparison of Survival in American and European Cancer Patients
    Gatta G.; Capocaccia R.; Coleman MP.; Gloeckler Ries L.A.; Hakulinen T.; Micheli A.; Sant M.; Verdecchia A.; and Berrino F.
    Cancer 2000;89:893-900. Document
  1. Understanding variations in survival for colorectal cancer in Europe:
    a EUROCARE high resolution study
    Gatta G.; Capocaccia R.; Sant M.; Bell C.M.J.; Coebergh J.W.W.; Damhuis R.A.M.;
    Faivre J.; Martinez-Garcia C.; et al.
    Gut 2000,47:533-538. Document
  1. Relative survival in elderly European cancer patients: evidence for
    health care inequalities
    Vercelli M.; Capocaccia R.; Quaglia A.; Casella C.; Puppo A.; Coebergh J.W.W..;
    EUROCARE Working Group.;
    Oncology Hematology 2000,35:161-179. Document
  1. Survival of cancer patients in Europe: the EUROCARE-2 Study
    Berrino F.; Capocaccia R.; Estève J.; Gatta G.; Hakulinen T.; Micheli A.; Sant M.;
    Verdecchia A. (editors)
    IARC Scientific Publication 1999,151.
  1. Mixture models for cancer survival analysis: application to population-based data with covariates
    De Angelis R.; Capocaccia R.; Hakulinen T.; Soderman B.; Verdecchia A.
    Statistics in Medicine 1999,18:441-454. Document
  1. Variatios in survival for invasive cervical cancer among European
    women, 1978-89
    Gatta G.; Capocaccia R.; Hakuline T.; Sant M.; Verdecchia A.; De Angelis G.; et al.
    Cancer Causes & Control 1999,10:575-581. Document
  1. Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country
    Sant M.; Capocaccia R.; Verdecchia A.; Esteve J.; Gatta G.; Micheli A.; Coleman M.P.;
    Berrino F.; EUROCARE Working Group.;
    International Journal of Cancer 1998,77:679-683. Document
  1. The prognostic role of gender in survival of adult cancer patients
    Micheli A.; Mariotto A.; Giorgi Rossi A.; Gatta G.; Muti P.; EUROCARE Working Group.;
    European Journal of Cancer 1998,34:2271-2278. Document
  1. Relative survival in elderly cancer patients in Europe
    Vercelli M.; Quaglia A.; Casella C.; Parodi S.; Capocaccia R.; Martinez Garcia C.;
    EUROCARE Working Group.;
    European Journal of Cancer 1998,34:2264-2270. Document
  1. Variatios in survival of adult patients with haematological malignancies in Europe since 1978
    Carli P.M.; Coebergh J.W.W.; Verdecchia A.; EUROCARE Working Group.;
    European Journal of Cancer 1998,34:2253-2263. Document
  1. Survival rates for primary malignant brain tumours in Europe
    Sant M.; van der Sanden G.; Capocaccia R.
    European Journal of Cancer 1998,34:2241-2247. Document
  1. Improved survival for patients with testicular cancer in Europe since 1978
    Aareleid T.; Sant M.; Hédelin G.
    European Journal of Cancer 1998,34:2236-2240. Document
  1. Improvement in survival of patients with cancer of the kidney in Europe
    Damhuis R.A.M.; Kirkels W.J.
    European Journal of Cancer 1998,34:2232-2235. Document
  1. Variation in survival of patients with prostate cancer in Europe since 1978
    Post P.N.; Damhuis R.A.M.; Van der Meyden A.P.M.
    European Journal of Cancer 1998,34:2226-2231. Document
  1. Survival of European women with gynaecological tumours, during the period 1978–1989
    Gatta G.; Lasota M.B.; Verdecchia A.
    European Journal of Cancer 1998,34:2218-2225. Document
  1. Survival of adult patients with cancer of soft tissues or bone in Europe
    Storm H.H.; EUROCARE Working Group.
    European Journal of Cancer 1998,34:2212-2217. Document
  1. Variations in survival from breast cancer in Europe by age and country,
    1978–1989
    Quinn M.J.; Martinez-Garcia C.; Berrino F.
    European Journal of Cancer 1998,34:2204-2211. Document
  1. Improving survival of melanoma patients in Europe since 1978
    Smith J.A.E.; Whatley P.M.; Redburn J.C.
    European Journal of Cancer 1998,34:2197-2203. Document
  1. Variation in survival of patients with lung cancer in Europe, 1985–1989
    Janssen-Heijnen M.L.G.; Gatta G.; Forman D.; Capocaccia R.; Coebergh J.W.W.
    European Journal of Cancer 1998,34:2191-2196. Document
  1. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe
    Faivre J.; Forman D.; Estève J.; Obradovic M.; Sant M.
    European Journal of Cancer 1998,34:2184-2190. Document
  1. Survival of colorectal cancer patients in Europe during the period 1978–1989
    Gatta G.; Faivre J.; Capocaccia R.; Ponz de Leon M.
    European Journal of Cancer 1998,34:2176-2183. Document
  1. Survival of patients with oesophageal and gastric cancers in Europe
    Faivre J.; Forman D.; Estève J.; Gatta G.
    European Journal of Cancer 1998,34:2167-2175. Document
  1. Variation in survival for adults with Nasopharyngeal cancer in Europe,
    1978–1989
    Jiong L.; Berrino F.; Coebergh J.W.W.
    European Journal of Cancer 1998,34:2162-2166. Document
  1. Variation in survival of patients with head and neck cancer in Europe
    by the site of origin of the tumours
    Berrino F.; Gatta G.
    European Journal of Cancer 1998,34:2154-2161. Dosument
  1. The EUROCARE II Study
    Berrino F.; Gatta G.; Chessa E.; Valente F.; Capocaccia R.
    European Journal of Cancer 1998,34:2139-2153. Document
  1. Survival of Adult Cancer Patients in Europe Diagnosed from 1978-1989:
    The EUROCARE II Study
    Coebergh J.W.W.; Sant M.; Berrino F.; Verdecchia A.
    European Journal of Cancer 1998,34:2137-2138. Document

 (top...)

EUROCARE-1

  1. The cure of colon cancer: results from the Eurocare Study
    Verdecchia A.; De Angelis R.; Capocaccia R.; Sant M.; Micheli A.; Gatta G.
    International Journal of Cancer 1998,77:322-329. Document
  1. Comparison of colon-cancer survival among european countries:
    the EUROCARE study
    Sant M.; Capocaccia R.; Verdecchia V.; Gatta G.; Micheli A.; Mariotto A.; Hakulinen T.; Berrino F.; EUROCARE Working Group.
    International Journal of Cancer 1995,63:43-48. Document
  1. Survival of cancer patients in Europe: the EUROCARE Study
    Berrino F.; Sant M.; Verdecchia V.; Capocaccia R.; Hakulinen T.; Estéve J.(editors)
    IARC Scientific Publication 1995,132.

 (top...)
 
© 2023 Istituto Superiore di Sanità - Settore I - Informatica